New drug cocktail aims to stop lymphoma from coming back after transplant
NCT ID NCT07276737
Summary
This study is testing a new three-drug combination given to patients before a stem cell transplant. The goal is to see if this new preparation method is more effective and safer for people with NK/T-Cell Lymphoma, specifically aiming to keep the cancer from returning after the transplant. It will involve 37 adult patients who have achieved remission and have a suitable donor.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NK/T-CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.